SCHEMBL8273228

SCHEMBL8273228

CC#CCn1c(N(C)CC(C)(C)N)nc2c1c(=O)n(Cc1ccc3ncccc3n1)c(=O)n2C

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 17/20 0.48
FAP Q12884 8/20 0.48
DPP9 Q86TI2 2/20 0.37
POU2F2 P09086 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
CHRM1 P11229 1/20 0.37
POU2F1 P14859 1/20 0.37
CHRM3 P20309 1/20 0.37
HRH2 P25021 1/20 0.37
MC4R P32245 1/20 0.37
DPP8 Q6V1X1 1/20 0.37
GHSR Q92847 1/20 0.37
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13955210 0.90 PKM (0.39) DPP4FAPHTTHSD17B10
SCHEMBL8271561 0.89 DPP4 (0.46) DPP4FAPDPP9CHRM1HTT
SCHEMBL8273233 0.89 DPP4 (0.51) DPP4FAPDPP9POU2F2ADORA3
SCHEMBL4476399 0.87 DPP4 (0.48) DPP4FAPDPP9POU2F2ADORA3
SCHEMBL4468648 0.87 DPP4 (0.48) DPP4FAPDPP9POU2F2ADORA3
SCHEMBL8273218 0.85 DPP4 (0.45) DPP4FAPDPP9CHRM1
SCHEMBL8273201 0.85 DPP4 (0.44) DPP4FAPDPP9CHRM1HTT
SCHEMBL8272357 0.84 DPP4 (0.41) DPP4FAPDPP9CHRM1
SCHEMBL4464092 0.82 DPP4 (0.46) DPP4DPP9CHRM1
SCHEMBL8272027 0.82 DPP4 (0.60) DPP4FAPDPP9POU2F2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7495002-B2 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-02-24 US disclosed
WO-2006029769-A1 NOVEL 3-METHYL-7-BUTINYL-XANTHINES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-03-23 WO disclosed